PortfoliosLab logo
CYCC vs. OMEX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CYCC and OMEX is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

CYCC vs. OMEX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cyclacel Pharmaceuticals, Inc. (CYCC) and Odyssey Marine Exploration, Inc. (OMEX). The values are adjusted to include any dividend payments, if applicable.

-100.00%-99.50%-99.00%-98.50%-98.00%-97.50%December2025FebruaryMarchAprilMay
-100.00%
-97.98%
CYCC
OMEX

Key characteristics

Sharpe Ratio

CYCC:

-0.45

OMEX:

-0.25

Sortino Ratio

CYCC:

-0.41

OMEX:

1.93

Omega Ratio

CYCC:

0.95

OMEX:

1.32

Calmar Ratio

CYCC:

-0.75

OMEX:

-0.71

Martin Ratio

CYCC:

-1.05

OMEX:

-0.98

Ulcer Index

CYCC:

71.33%

OMEX:

71.87%

Daily Std Dev

CYCC:

166.63%

OMEX:

279.64%

Max Drawdown

CYCC:

-100.00%

OMEX:

-99.70%

Current Drawdown

CYCC:

-100.00%

OMEX:

-98.91%

Fundamentals

Market Cap

CYCC:

$50.69M

OMEX:

$31.79M

EPS

CYCC:

-$2.09

OMEX:

$0.07

PEG Ratio

CYCC:

0.00

OMEX:

0.00

PS Ratio

CYCC:

1.47K

OMEX:

41.35

PB Ratio

CYCC:

2.02

OMEX:

0.00

Total Revenue (TTM)

CYCC:

$14.00K

OMEX:

$565.61K

Gross Profit (TTM)

CYCC:

$12.00K

OMEX:

-$1.65M

EBITDA (TTM)

CYCC:

-$7.70M

OMEX:

-$10.80M

Returns By Period

In the year-to-date period, CYCC achieves a 40.89% return, which is significantly lower than OMEX's 51.39% return. Over the past 10 years, CYCC has underperformed OMEX with an annualized return of -57.99%, while OMEX has yielded a comparatively higher -17.87% annualized return.


CYCC

YTD

40.89%

1M

130.25%

6M

-15.51%

1Y

-73.52%

5Y*

-61.63%

10Y*

-57.99%

OMEX

YTD

51.39%

1M

189.66%

6M

112.89%

1Y

-70.14%

5Y*

-25.09%

10Y*

-17.87%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CYCC vs. OMEX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CYCC
The Risk-Adjusted Performance Rank of CYCC is 2222
Overall Rank
The Sharpe Ratio Rank of CYCC is 2626
Sharpe Ratio Rank
The Sortino Ratio Rank of CYCC is 2525
Sortino Ratio Rank
The Omega Ratio Rank of CYCC is 2626
Omega Ratio Rank
The Calmar Ratio Rank of CYCC is 77
Calmar Ratio Rank
The Martin Ratio Rank of CYCC is 2525
Martin Ratio Rank

OMEX
The Risk-Adjusted Performance Rank of OMEX is 4949
Overall Rank
The Sharpe Ratio Rank of OMEX is 3737
Sharpe Ratio Rank
The Sortino Ratio Rank of OMEX is 8484
Sortino Ratio Rank
The Omega Ratio Rank of OMEX is 8989
Omega Ratio Rank
The Calmar Ratio Rank of OMEX is 99
Calmar Ratio Rank
The Martin Ratio Rank of OMEX is 2727
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CYCC vs. OMEX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Cyclacel Pharmaceuticals, Inc. (CYCC) and Odyssey Marine Exploration, Inc. (OMEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for CYCC, currently valued at -0.45, compared to the broader market-2.00-1.000.001.002.003.00
CYCC: -0.45
OMEX: -0.25
The chart of Sortino ratio for CYCC, currently valued at -0.41, compared to the broader market-6.00-4.00-2.000.002.004.00
CYCC: -0.41
OMEX: 1.93
The chart of Omega ratio for CYCC, currently valued at 0.95, compared to the broader market0.501.001.502.00
CYCC: 0.95
OMEX: 1.32
The chart of Calmar ratio for CYCC, currently valued at -0.75, compared to the broader market0.001.002.003.004.005.00
CYCC: -0.75
OMEX: -0.71
The chart of Martin ratio for CYCC, currently valued at -1.05, compared to the broader market-40.00-30.00-20.00-10.000.0010.0020.00
CYCC: -1.05
OMEX: -0.98

The current CYCC Sharpe Ratio is -0.45, which is lower than the OMEX Sharpe Ratio of -0.25. The chart below compares the historical Sharpe Ratios of CYCC and OMEX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.70-0.60-0.50-0.40-0.30-0.20December2025FebruaryMarchAprilMay
-0.45
-0.25
CYCC
OMEX

Dividends

CYCC vs. OMEX - Dividend Comparison

CYCC's dividend yield for the trailing twelve months is around 59.71%, while OMEX has not paid dividends to shareholders.


TTM202420232022202120202019201820172016
CYCC
Cyclacel Pharmaceuticals, Inc.
59.71%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%
OMEX
Odyssey Marine Exploration, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

CYCC vs. OMEX - Drawdown Comparison

The maximum CYCC drawdown since its inception was -100.00%, roughly equal to the maximum OMEX drawdown of -99.70%. Use the drawdown chart below to compare losses from any high point for CYCC and OMEX. For additional features, visit the drawdowns tool.


-100.00%-99.50%-99.00%-98.50%December2025FebruaryMarchAprilMay
-100.00%
-98.91%
CYCC
OMEX

Volatility

CYCC vs. OMEX - Volatility Comparison

The current volatility for Cyclacel Pharmaceuticals, Inc. (CYCC) is 89.78%, while Odyssey Marine Exploration, Inc. (OMEX) has a volatility of 115.44%. This indicates that CYCC experiences smaller price fluctuations and is considered to be less risky than OMEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


20.00%40.00%60.00%80.00%100.00%120.00%December2025FebruaryMarchAprilMay
89.78%
115.44%
CYCC
OMEX

Financials

CYCC vs. OMEX - Financials Comparison

This section allows you to compare key financial metrics between Cyclacel Pharmaceuticals, Inc. and Odyssey Marine Exploration, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00K400.00K600.00K800.00K1.00M202120222023202420250
136.15K
(CYCC) Total Revenue
(OMEX) Total Revenue
Values in USD except per share items